Literature DB >> 25524714

Unusual c-KIT+ squamous cell carcinoma of the uterine cervix showing paradoxical hypermethylation of the c-KIT proto-oncogene.

Wan-Ru Chao1, Wea-Lung Lin2, Chi-Kuan Chen3, Lih-Min Han4, Jau-Chen Lin5, Chih-Ping Han6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25524714     DOI： 10.1016/j.ejogrb.2014.11.034

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


× No keyword cloud information.
  5 in total

Review 1.  Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.

Authors:  Niyati Sudhalkar; Nidul P Rathod; Ashwathi Mathews; Supriya Chopra; Harshini Sriram; Shyam K Shrivastava; Jayant S Goda
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-08

Review 2.  Epigenetic therapy in urologic cancers: an update on clinical trials.

Authors:  Inês Faleiro; Ricardo Leão; Alexandra Binnie; Ramon Andrade de Mello; Ana-Teresa Maia; Pedro Castelo-Branco
Journal:  Oncotarget       Date:  2017-02-14

Review 3.  KIT and Melanoma: Biological Insights and Clinical Implications.

Authors:  Duc Daniel M Pham; Samantha Guhan; Hensin Tsao
Journal:  Yonsei Med J       Date:  2020-07       Impact factor: 2.759

Review 4.  A promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ----- CTCF transcriptional repressor regulates c-KIT proto-oncogene expression.

Authors:  Shih-Wen Chang; Wan-Ru Chao; Alexandra Ruan; Po-Hui Wang; Jau-Chen Lin; Chih-Ping Han
Journal:  Diagn Pathol       Date:  2015-11-25       Impact factor: 2.644

Review 5.  Cancer stem cells (CSCs), cervical CSCs and targeted therapies.

Authors:  Ruixia Huang; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.